|
CBIO | Gyre Therapeutics, Inc. |
|
|
CBIO | Gyre Therapeutics, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 4.81 |
| Leverage | 21.53% |
| Market Cap | $ 20.5m |
| PE | 1.14 |
| Dividend Yield | 0.00% |
| Profit | $ 17.9m |
| Margin | 17.28% |